Novo Nordisk's Wegovy obesity drug reduced adverse kidney-related events by 22% in overweight and obese people in a large study, according to a new analysis the
GSK shares fell as much as 7% on Thursday, a day after a U.S. public health agency narrowed its age recommendation for use of respiratory syncytial virus
Eleven-year-old Noor's left leg was almost entirely torn off when her home in Jabalia, Gaza was hit by an explosion in
Israeli forces unleashed an aerial and ground blitz against Hamas in Gaza after a cross-border rampage by the enclave's ruling
Tens of thousands of displaced Palestinians have crammed into the Rafah area on Gaza's border with Egypt to escape Israeli bombardments,
Facing a soaring death toll from Israel's renewed offensive in southern Gaza, the Biden administration is trying to
Eli Lilly on Thursday said it has not yet gained approval in Britain for the injection pen it plans to use for its Mounjaro drug against obesity and
Soaring demand for obesity drugs was in the spotlight at the world's largest trade show for the pharmaceutical services industry this week, as it fuels a boom for
Obesity drug-maker Novo Nordisk will spend $4.1 billion to build a U.S. facility to fill injection pens for its hugely popular
British drugmaker GSK on Wednesday bought partner CureVac out of their alliance on influenza and COVID-19 vaccine development, boosting its messenger RNA credentials and extending the
Patients with type 2 diabetes taking GLP-1 treatments, which include Ozempic, have a lower chance of developing 10 types of obesity-related cancers than those taking
Democratic U.S.
The world's second vaccine against malaria was launched on Monday as Ivory Coast began a routine vaccine programme using shots developed by the University of Oxford
Swiss biotech company Asceneuron said on Tuesday it had raised $100 million from investors including the controlling shareholder of Wegovy maker Novo Nordisk to fund
Anglo-Swedish drugmaker AstraZeneca raised its full year sales and profit forecast on Thursday after beating analyst expectations for second-quarter
As Eli Lilly's weight-loss drug Zepbound gains ground in the U.S. against Novo Nordisk's Wegovy, some doctors say their guiding
Novo Nordisk on Wednesday trimmed its full-year profit outlook after reporting weaker-than-expected quarterly sales of its popular weight-loss drug Wegovy, stirring
Alzheimer's patients in Britain's state-run health service are unlikely to get access to Eisai and Biogen's new Leqembi drug, after it was approved on Thursday by the
Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish drugmaker's experimental
U.S. consumer groups and two large labor unions urged the U.S.
GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory syncytial virus (RSV) and
EU antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings' acquisition of contract drug manufacturer Catalent, according
Novo Nordisk reported forecast-beating third-quarter sales of its popular Wegovy weight-loss drug on Wednesday, reassuring investors
Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong demand for its cancer and
EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' planned $16.5
BOJ Governor Ueda's comments at news conference
China set to keep lending rates steady on positive signs for economic recovery
Volkswagen sells 360-million-euro Traton stake for 32.75 euros per share
Japan Airlines to buy 17 more Boeing 737-8s
Openly gay soccer player still faces online death threats
CBS' '60 Minutes' is unflinching in its White House coverage in the shadow of Trump's $20B lawsuit
